Tower Research Capital (TRC)’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-13,436
| Closed | -$15K | – | 5400 |
|
|
2025
Q2 | $15K | Buy |
13,436
+6,217
| +86% | +$7.59K | ﹤0.01% | 3822 |
|
|
2025
Q1 | $8.3K | Buy |
7,219
+3,780
| +110% | +$7.03K | ﹤0.01% | 3905 |
|
|
2024
Q4 | $21K | Buy |
3,439
+2,510
| +270% | +$29.8K | ﹤0.01% | 3148 |
|
|
2024
Q3 | $15.4K | Sell |
929
-2,699
| -74% | -$29.6K | ﹤0.01% | 3413 |
|
|
2024
Q2 | $24.9K | Buy |
3,628
+3,370
| +1,306% | +$28.8K | ﹤0.01% | 3623 |
|
|
2024
Q1 | $2.49K | Sell |
258
-1,284
| -83% | -$14.9K | ﹤0.01% | 5025 |
|
|
2023
Q4 | $12.8K | Sell |
1,542
-1,356
| -47% | -$7.87K | ﹤0.01% | 4013 |
|
|
2023
Q3 | $24.2K | Buy |
2,898
+382
| +15% | +$3.24K | ﹤0.01% | 3203 |
|
|
2023
Q2 | $23.2K | Sell |
2,516
-3,606
| -59% | -$40.4K | ﹤0.01% | 3250 |
|
|
2023
Q1 | $84K | Buy |
6,122
+5,524
| +924% | +$114K | ﹤0.01% | 2021 |
|
|
2022
Q4 | $10K | Sell |
598
-1,421
| -70% | -$28.4K | ﹤0.01% | 4013 |
|
|
2022
Q3 | $46K | Sell |
2,019
-2,833
| -58% | -$57.2K | ﹤0.01% | 3231 |
|
|
2022
Q2 | $87K | Sell |
4,852
-5,971
| -55% | -$106K | ﹤0.01% | 2401 |
|
|
2022
Q1 | $289K | Buy |
10,823
+8,736
| +419% | +$163K | ﹤0.01% | 1487 |
|
|
2021
Q4 | $61K | Buy |
2,087
+1,301
| +166% | +$64.6K | ﹤0.01% | 2612 |
|
|
2021
Q3 | $52K | Sell |
786
-66
| -8% | -$5.05K | ﹤0.01% | 2934 |
|
|
2021
Q2 | $71K | Sell |
852
-751
| -47% | -$55.6K | ﹤0.01% | 2722 |
|
|
2021
Q1 | $123K | Buy |
1,603
+652
| +69% | +$59.3K | ﹤0.01% | 2427 |
|
|
2020
Q4 | $84K | Sell |
951
-303
| -24% | -$21.3K | ﹤0.01% | 2521 |
|
|
2020
Q3 | $92K | Sell |
1,254
-1,700
| -58% | -$101K | ﹤0.01% | 3205 |
|
|
2020
Q2 | $216K | Buy |
2,954
+2,752
| +1,362% | +$167K | 0.01% | 1720 |
|
|
2020
Q1 | $11K | Buy |
+202
| New | +$8.85K | ﹤0.01% | 1971 |
|
Other funds holding IGMS
Tower Research Capital (TRC)'s IGMS Position: Q3 2025 in Review
Tower Research Capital (TRC) sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 13,436 shares — an estimated $15K sold.
Tower Research Capital (TRC) first reported a position in IGMS in Q1 2020 and held it in 22 quarters. The position peaked at $289K in Q1 2022. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.
- Tower Research Capital (TRC) reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
- Tower Research Capital (TRC) sold 13,436 IGM Biosciences shares in Q3 2025, an estimated $15K.
- Tower Research Capital (TRC) first reported a position in IGM Biosciences in Q1 2020 and held it in 22 quarters.
- Tower Research Capital (TRC)'s IGM Biosciences position peaked at $289K in Q1 2022.
- 1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2025, filed 14 Nov 2025.